Health CanadaGeneral Alert
TECENTRIQ (atezolizumab) - Risk of Myocarditis
Published: February 14, 2018Recall ID: 58038Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
TECENTRIQ (atezolizumab) - Risk of Myocarditis
Recalling Firm: Marketed health products
Product Description & Identification
TECENTRIQ (atezolizumab) - Risk of Myocarditis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58038 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/tecentriq-atezolizumab-risk-myocarditis |
| Title | TECENTRIQ (atezolizumab) - Risk of Myocarditis |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2018-02-14 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - TECENTRIQ (atezolizumab) - Risk of Myocarditis Check if your household is affected: https://therecallfile.com/recalls/tecentriq-atezolizumab-risk-of-myocarditis/CANADA-58038
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordTECENTRIQ (atezolizumab) - Risk of Myocarditis